Scanner

ABBV — AbbVie

Healthcare

Yahoo Finance

Last price

$168.55

2025-01-30

52w high

$193.80

-13.0% off high

5yr return

75%

since 2021-05-24

Active modes

0/3

BUY or WATCH

Price chart — last 12 months

Price with 50-day & 200-day MAs. Colored dots mark historical reversal-signal firings — see legend below.

Signal events on chart (last 252 days)

RSI crossed 50×12

50DMA reclaimed×5

Golden cross—

Higher lows (5)×8

Volume accumulation×20

Bullish RSI divergence×2

Oversold / Fear

SKIP

🚀 At highs2/8·12w

Quality gate failed: ROIC 13.0% < 15%; revenue CAGR -28.7% < 8%.

↻ Golden cross: 50DMA crossed above 200DMA within last 30 days · Earnings in 11 days (catalyst window)

Acceleration

SKIP

🚀 At highs2/8·12w

Quality gate failed: ROIC 13.0% < 15%; revenue CAGR -28.7% < 8%.

↻ Golden cross: 50DMA crossed above 200DMA within last 30 days · Earnings in 11 days (catalyst window)

Quality at Fair Price

SKIP

🚀 At highs2/8·12w

Quality gate failed: ROIC 13.0% < 15%; revenue CAGR -28.7% < 8%.

↻ Golden cross: 50DMA crossed above 200DMA within last 30 days · Earnings in 11 days (catalyst window)

Score trajectory

How the score has evolved across recent scans for each mode. Rising score = setup forming.

Annual fundamentals

From yahoo fundamentalsTimeSeries (annual cadence).

Year-end	Revenue	FCF	Gross %	Op %	ROIC	EPS
2026-03-31	15.00B	3.56B	71.9%	31.6%	13.0%	$0.39
2025-12-31	61.16B	19.03B	70.2%	32.9%	31.3%	$—
2024-12-31	56.33B	18.81B	70.0%	21.1%	16.9%	$—
2023-12-31	54.32B	22.84B	62.4%	24.9%	19.4%	$—
2022-12-31	58.05B	24.94B	70.0%	32.4%	23.4%	$—
2021-12-31	56.20B	22.78B	69.0%	33.9%	20.7%	$—
2020-12-31	45.80B	17.59B	66.4%	27.8%	12.8%	$—
2019-12-31	33.27B	13.32B	77.6%	40.2%	22.8%	$—

Universe metadata

Healthcare

Hand off to Claude for qualitative deep-dive

Claude deep-dive prompt

My stock-scanner has flagged ABBV with the following signals across multiple scoring modes:

1. Quality gate failed or no signals firing across all 3 modes — the framework currently sees no setup. Why might that be?

Please do a current deep-dive on ABBV:

1. What's the actual business / what do they sell, in plain English?
2. Recent news + narrative: why is the market pricing this where it is right now? What's the bear case being priced in?
3. Is the long-term thesis intact, or has something fundamentally broken (moat erosion, secular decline, management issues)?
4. What's the upcoming catalyst calendar — earnings, product launches, regulatory dates?
5. Compare to peers: cheaper than peers / more expensive / similar?
6. If buying: is now the right entry, or is there a smarter staged-accumulation plan? Suggest specific price levels.
7. What's the biggest risk to a long position from here?

Use web search for any recent news (last 30 days) to ground your answer in current reality, not training cutoff.